Fresenius Medical Care AG (FMS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 21.76 |
| Open | 21.80 |
| Bid | 21.87 x 900 |
| Ask | 21.87 x 1000 |
| Day's range | 21.67 - 21.97 |
| 52-week range | 16.37 - 27.72 |
| Volume | |
| Avg. volume | 462,703 |
| Market cap | 12.901B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 24.41 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.63 (2.89%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
- PR Newswire
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets
Fresenius Medical Care (FME), the global leader in providing products and services for people with kidney diseases, is executing its strategic turnaround plan and is well on track to achieve its goals for 2024.
- PR Newswire
Fresenius Medical Care starts the year with strong earnings growth
Helen Giza, Chief Executive Officer of Fresenius Medical Care, said:
- PR Newswire
Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today published its joint 2023 Annual Report and Non-financial Group Report, available digitally on the corporate website. Titled "Shaping the Future of Kidney Care," the report provides detailed information about Fresenius Medical Care's economic, social and environmental performance in 2023.
© 2024 Yahoo. All rights reserved.